Advertisement

Classification and treatment of orbital venous malformations: an updated review

  • Tianyuan Li
  • Renbing Jia
  • Xianqun Fan
Review
  • 17 Downloads

Abstract

Orbital venous malformation (OVM) is a congenital vascular disease. As a common type of vascular malformation in the orbit, OVM may result in vision deterioration and cosmetic defect. Classification of orbital vascular malformations, especially OVMs, is carried out on the basis of different categories, such as angiogenesis, hemodynamics, and locations. Management of OVM is complicated and challenging. Treatment approaches include sclerotherapy, laser therapy, embolization, surgical resection, and radiotherapy. A satisfactory outcome can be achieved only by selecting the appropriate treatment according to lesion characteristics and following the sequential multi-method treatment strategy. This article summarizes the current classification and treatment advances in OVM.

Keywords

orbit venous malformation treatment sclerotherapy laser embolization 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    ISSVA classifiaction for vascular anomalies. www.issva.org. 2014Google Scholar
  2. 2.
    Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69(3): 412–420CrossRefPubMedGoogle Scholar
  3. 3.
    Rootman J, Heran MKS, Graeb DA. Vascular malformations of the orbit: classification and the role of imaging in diagnosis and treatment strategies. Ophthal Plast Reconstr Surg 2014; 30(2): 91–104CrossRefPubMedGoogle Scholar
  4. 4.
    Rootman J. Venous malformation. In: Rootman J, Marrota TR, Graeb DA. Diseases of the Orbit: A Multidisciplinary Approach. 2nd ed. Philadelphia: Lippincott Williams and wilkins, 2003: 517–522Google Scholar
  5. 5.
    Chung CF, Lai JS. Enophthalmos caused by an orbital venous malformation. Hong Kong Med J 2009; 15(4): 299–300PubMedGoogle Scholar
  6. 6.
    Yen MT. Imaging vascular lesions of the orbit and face. In: Poll J, Yen MT, Mukerji SK. Vascular Lesions of Orbit and Face. Springer, 2016: 11–17CrossRefGoogle Scholar
  7. 7.
    Yen MT. Low-flow vascular malformations of the orbit: evaluation and management. In: Pimpalwar S, Chinnadurai P, Marx DP. Vascular Lesions of Orbit and Face. Springer, 2016: 89–99CrossRefGoogle Scholar
  8. 8.
    Arat YO, Mawad ME, Boniuk M. Orbital venous malformations—current multidisciplinary treatment approach. Arch Ophthalmol 2004; 122(8): 1151–1158CrossRefPubMedGoogle Scholar
  9. 9.
    Jia R, Xu S, Huang X, Song X, Pan H, Zhang L, He F, Lin M, Ge S, Fan X. Pingyangmycin as first-line treatment for low-flow orbital or periorbital venous malformations: evaluation of 33 consecutive patients. JAMA Ophthalmol 2014; 132(8): 942–948CrossRefPubMedGoogle Scholar
  10. 10.
    Dai W, Li L, Lin G. Clinical observation of pingyangmycin in treatment of 18 orbital neoplasm. J North China Coal Med Univ (Hua Bei Mei Tan Yi Xue Yuan Bao) 2011; 13: 665–666 (in Chinese)Google Scholar
  11. 11.
    Li J, Lin M, Jia R. Histopathological and immunohistochemical studies of orbital venous malformations after pingyangmycin and Nd:YAG laser local treatment. Ophthalmol CHN (Yan Ke) 2011; 20: 274–278 (in Chinese)Google Scholar
  12. 12.
    Lin M, Li J, Jia R. The combined effects of pingyangmycin and Nd: YAG laser in treatment of nondistensible orbital venous malformations. Chin J Pract Ophthalmol (Zhongguo Shi Yong Yan Ke Za Zhi) 2011; 29: 962–965 (in Chinese)Google Scholar
  13. 13.
    Yue H, Qian J, Elner VM, Guo J, Yuan YF, Zhang R, Ge Q. Treatment of orbital vascular malformations with intralesional injection of pingyangmycin. Br J Ophthalmol 2013; 97(6): 739–745CrossRefPubMedGoogle Scholar
  14. 14.
    Shen CY, Wu MC, Tyan YS, Ou CH, Chen TY, Wong HF. Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery. Clin Radiol 2012; 67(2): 182–184CrossRefPubMedGoogle Scholar
  15. 15.
    Chiramel GK, Keshava SN, Moses V, Mammen S, David S, Sen S. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit. Cardiovasc Intervent Radiol 2015; 38 (2): 270–279CrossRefPubMedGoogle Scholar
  16. 16.
    Lima V, Burt B, Leibovitch I, Prabhakaran V, Goldberg RA, Selva D. Orbital compartment syndrome: the ophthalmic surgical emergency. Surv Ophthalmol 2009; 54(4): 441–449CrossRefPubMedGoogle Scholar
  17. 17.
    Horbach SE, Lokhorst MM, Saeed P, de Goüyon Matignon de Pontouraude CM, Rothavá A, van der Host CM. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 2016; 69 (3): 295–304CrossRefPubMedGoogle Scholar
  18. 18.
    Blum RH, Carter SK, Arge K. A clinical review of bleomycin—a new antineoplastic agent. Cancer 1973; 31(4): 903–914CrossRefPubMedGoogle Scholar
  19. 19.
    Zhang Q. Local injection of bleomycin A 5 in chilrdren with hemangiomas: analysis of 210 cases. Chin J Surg (Zhonghua Wai Ke Za Zhi) 1991; 29: 290–291 (in Chinese)Google Scholar
  20. 20.
    Zheng JW, Yang XJ, Wang YA, He Z, Ye WM, Zhang ZY. Intralesional injection of pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients. Oral Oncol 2009; 45(10): 872–876CrossRefPubMedGoogle Scholar
  21. 21.
    Mungunsukh O, Griffin AJ, Lee YH, Day RM. Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 2010; 298(5): L696–L703CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Wang C, Liu J, Pan W, Wang X, Gao Q, Hou S. Pingyangmycin loaded bovine serum albumin microspheres for chemoembolization therapy—in vitro and in vivo studies. Int J Pharm 2008; 351(1–2): 219–226CrossRefPubMedGoogle Scholar
  23. 23.
    Lin M, Fan X. Advances in treatment of orbital venous malformations. J Clin Oph (Lin Chuang Yan Ke Za Zhi) 2011; 19: 368–371 (in Chinese)Google Scholar
  24. 24.
    Burger RM, Peisach J, Horwitz SB. Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J Biol Chem 1981; 25;256(22): 11636–11644Google Scholar
  25. 25.
    Tai KW, Chang YC, Chou LS, Chou MY. Cytotoxic effect of pingyangmycin on cultured KB cells. Oral Oncol 1998; 34(3): 219–223CrossRefPubMedGoogle Scholar
  26. 26.
    Zeng Q, Li Y, Chen Y, Xu X, Lu E, Wang J. The experimental study of intra-arterial infusion of pingyangmycinlipiodol emulsion in rabbits. J Clin Radiol (Lin Chuang Fang She Xue Za Zhi) 2000; 19 (6): 376–379 (in Chinese)Google Scholar
  27. 27.
    Kong W, Li Y, Zeng Q, Chen Y, He XF. Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells. J First Mil Med Univ (Di Yi Jun Yi Da Xue Xue Bao) 2003; 2003(23): 830–832 (in Chinese)Google Scholar
  28. 28.
    Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate. Int J Oral Maxillofac Surg 2004; 33(5): 463–466CrossRefPubMedGoogle Scholar
  29. 29.
    Chiramel GK, Keshava SN, Moses V, Mammen S, David S, Sen S. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit. Cardiovasc Intervent Radiol 2015; 38 (2): 270–279CrossRefPubMedGoogle Scholar
  30. 30.
    Sung MW, Chang SO, Choi JH, Kim JY. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. Am J Otolaryngol 1995; 16(4): 236–241CrossRefPubMedGoogle Scholar
  31. 31.
    Zeng Q, Li Y, Zhu Q. Pingyangmycin lipiodol emulsion intracavitary injection in the treatment of superficial venous malformations. J Intervent Radiol (Jie Ru Fang She Xue Za Zhi) 2001; 10: 274–276 (in Chinese)Google Scholar
  32. 32.
    Chen Y, Li Y, Zhu Q, Zeng Q, Zhao J, He X, Mei Q. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. AJR Am J Roentgenol 2008; 190(4): 966–971CrossRefPubMedGoogle Scholar
  33. 33.
    Stroncek DF, Hutton SW, Silvis SE, Vercellotti GM, Jacob HS, Hammerschmidt DE. Sodium morrhuate stimulates granulocytes and damages erythrocytes and endothelial cells: probable mechanism of an adverse reaction during sclerotherapy. J Lab Clin Med 1985; 106(5): 498–504PubMedGoogle Scholar
  34. 34.
    Zhao J, Zhao Y, Chen X. A comparative study on the blood vessel sclerosing effect of pingyungmycin and Natrii morrhuates. West Chin J Stomatol ( Hua Xi Kou Qiang Yi Xue Za Zhi) 1997; 15(2): 97–98 (in Chinese)Google Scholar
  35. 35.
    He W, Gu AL, Shang JL. Comparison of the clinical therapeutic effects between local injection of pingyangmycin and sodium morrhuate on oral and maxillofacial venous malformation. Chin J Stomatol (Zhong Hua Kou Qiang Yi Xue Za Zhi) 2007; 42(5): 308–309 (in Chinese)Google Scholar
  36. 36.
    Orlando JL, Caldas JG, Campos HG, Nishinari K, Krutman M, Wolosker N. Ethanol sclerotherapy of head and neck venous malformations. Einstein (Sao Paulo) 2014; 12(2): 181–186CrossRefGoogle Scholar
  37. 37.
    Lacey B, Rootman J, Marotta TR. Distensible venous malformations of the orbit: clinical and hemodynamic features and a new technique of management. Ophthalmology 1999; 106(6): 1197–1209CrossRefPubMedGoogle Scholar
  38. 38.
    Chen H, Lin X, Jin Y. Treatment of localized upper eyelid venous malformations by double-needle absolute ethanol sclerotherapy. Chin J Aesth Plast Surg (Zhongguo Mei Rong Zheng Xing Wai Ke Za Zhi) 2011; 22: 535–537 (in Chinese)Google Scholar
  39. 39.
    Alexander MD, McTggart RA, Choudhri OA, Marcellus ML, Do HM. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck. J Neurointerv Surg 2014; 6(9): 695–698CrossRefPubMedGoogle Scholar
  40. 40.
    Costa JR, Torriani MA, Hosni ES, D’Avila OP, de Figueiredo PJ. Sclerotherapy for vascular malformations in the oral and maxillofacial region: treatment and follow-up of 66 lesions. J Oral Maxillofac Surg 2011; 69(6): e88–e92CrossRefPubMedGoogle Scholar
  41. 41.
    Hoque S, Das BK. Treatment of venous malformations with ethanolamine oleate: a descirptive study of 83 cases. Pediatr Surg Int 2011; 27(5): 527–531CrossRefPubMedGoogle Scholar
  42. 42.
    Brothers MF, Kaufmann JC, Fox AJ, Deveikis JP. n-Butyl 2- cyanoacrylate–substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. Am J Neuroradiol 1989; 10(4): 777–786PubMedGoogle Scholar
  43. 43.
    Garcia DD, Heran MK, Amadi AJ, Rootman J. Low outflow distensible venous malformations of the anterior orbit: presentation, hemodynamic factors and management. Ophthal Plast Reconstr Surg 2011; 27(1): 38–43CrossRefPubMedGoogle Scholar
  44. 44.
    Couch SM, Garrity JA, Cameron JD, Rootman J. Embolization of orbital varices with N-butyl cyanoacrylate as an aid in surgical excision: results of 4 cases with histopathologic examination. Am J Ophthalmol 2009; 148(4): 614–618.e1CrossRefPubMedGoogle Scholar
  45. 45.
    Mokhtarzadeh A, Garrity JA, Cloft HJ. Recurrent orbital varices after surgical excision with and without prior embolization with nbutyl cyanoacrylate. Am J Ophthalmol 2014; 157(2): 447–450.e1CrossRefPubMedGoogle Scholar
  46. 46.
    Guglielmi G, Vinuela F, Sepetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach. Part 1: Electrochemical basis, technique, and experimental results. J Neurosurg 1991; 75(1): 1–7CrossRefPubMedGoogle Scholar
  47. 47.
    Guglielmi G, Vinuela F, Sepetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach. Part 2: Preliminary clinical experience. J Neurosurg 1991; 75(1): 8–14PubMedGoogle Scholar
  48. 48.
    Diolaiuti S, Iizuka T, Schroth G, Remonda L, Laedrach K, El- Koussy M, Frueh BE, Goldblum D. Orbital venous malformation: percutaneous treatment using an electrolytically detachable fibred coil. Acta Ophthalmologica 2009; 87(2): 229–232CrossRefPubMedGoogle Scholar
  49. 49.
    Takechi A, Uozumi T, Kiya K, Yano T, Sumida M, Yoshikawa S, Pant B. Embolisation of orbital varix. Neuroradiology 1994; 36(6): 487–489CrossRefPubMedGoogle Scholar
  50. 50.
    Weill A, Cognard C, Castaings L, Robert G, Moret J. Embolization of an orbital varix after surgical exposure. AJNR Am J Neuroradiol 1998; 19(5): 921–923PubMedGoogle Scholar
  51. 51.
    Van Rooij WJ, DeGast AN, Sluzewski M. Results of 101 aneurysms treated with polyglycolic/polylactic acid microfilament nexus coils compared with historical controls treated with standard coils. Am J Neuroradiol 2008; 29(5): 991–996CrossRefPubMedGoogle Scholar
  52. 52.
    Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220(4596): 524–527CrossRefPubMedGoogle Scholar
  53. 53.
    Liu G, Liu X, Li W, Shi H, Ye K, Yin M, Huang Y, Lu X, Huang X, Lu M, Jiang M. Ultrasound-guided intralesional diode laser treatment of congenital extratruncular venous malformations: midterm results. Eur J Vasc Endovasc Surg 2014; 47(5): 558–564CrossRefPubMedGoogle Scholar
  54. 54.
    Proebstle TM, Lehr HA, Kargl A, Espinola-Klein C, Rother W, Bethge S, Knop J. Endovenous treatment of the greater saphenous vein with a 940-nm diode laser: thrombotic occlusion after endoluminal thermal damage by laser-generated steam bubbles. J Vasc Surg 2002; 35(4): 729–736CrossRefPubMedGoogle Scholar
  55. 55.
    Levine VJ, Geronemus RG. Adverse effects associated with the 577-and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: a study of 500 patients. J Am Acad Dermatol 1995; 32(4): 613–617CrossRefPubMedGoogle Scholar
  56. 56.
    Buainian H, Verhaeghe E, Dierckxsens L, Naeyaert JM. Early treatment of hemangiomas with lasers. A review. Dermatology 2003; 206(4): 370–373CrossRefPubMedGoogle Scholar
  57. 57.
    Glaessl A, Schreyer AG, Wimmershoff MB, Landthaler M, Feuerbach S, Hohenleutner U. Laser surgical planning with magnetic resonance imaging-based 3-dimensional reconstructions for intralesional Nd:YAG laser therapy of a venous malformation of the neck. Arch Dermatol 2001; 137(10): 1331–1335CrossRefPubMedGoogle Scholar
  58. 58.
    Vlachakis I, Gardikis S, Michailoudi E, Charissis G. Treatment of hemangiomas in children using a Nd:YAG laser in conjunction with ice cooling of the epidermis: techniques and results. BMC Pediatr 2003; 3:2CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Lin M, Li J, Jia RB, Fu Y, Fan XQ. Surgical flap and Nd:YAG lasers coagulation in the treatment of nondistensible orbital venous malformations. Ophthalmol CHN (Yan Ke) 2009; 8: 395–398 (in Chinese)Google Scholar
  60. 60.
    Fan XQ, Xiao CW, Zhou GY, Jia RB, Fu Y, Zhou HF. Treatment of orbital venous malformation using surgical procedure combined with Nd:YAG laser. Chin J Ophthalmol (Zhonghua Yan Ke Za Zhi) 2008; 44(8): 681–686 (in Chinese)Google Scholar
  61. 61.
    Bagazgoitia L, Boixeda P, Lopez-Caballero C, Beà S, Santiago JL, Jaén P. Venous malformation of the eyelid treated with pulsed-dye- 1064-nm neodymium yttrium aluminum garnet sequential laser: an effective and safe treatment. Ophthal Plast Reconstr Surg 2008; 24 (6): 488–490CrossRefPubMedGoogle Scholar
  62. 62.
    Burke RM, Morin RJ, Perlyn CA, Laure B, Wolfe SA. Special considerations in vascular anomalies: operative management of craniofacial osseous lesions. Clin Plast Surg 2011; 38(1): 133–142CrossRefPubMedGoogle Scholar
  63. 63.
    Tan ST, Bialostocki A, Brasch H, Fitzjohn T. Venous malformation of the orbit. J Oral Maxillofac Surg 2004; 62(10): 1308–1311CrossRefPubMedGoogle Scholar
  64. 64.
    Li Y, Fan X. Application of computer-aided surgical navigation system in orbital surgery. Chin J Ophthalmol (Zhonghua Yan Ke Za Zhi) 2011; 47(8): 759–761 (in Chinese)Google Scholar
  65. 65.
    Ernemann U, Westendorff C, Troitzsch D, Hoffmann J. Navigationassisted sclerotherapy of orbital venolymphatic malformation: a new guidance technique for percutaneous treatment of low-flow vascular malformations. Am J Neuroradiol 2004; 25(10): 1792–1795PubMedGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Ophthalmology, Shanghai Ninth People’s HospitalShanghai Jiao Tong University School of MedicineShanghaiChina

Personalised recommendations